National Organization for Medicines

Eliminating Stamp Duty on 600 Transactions for Cost Savings and Efficiency

A draft law that abolishes the Stamp Duty on more than 600 transactions and introduces a Digital Transaction Fee for transactions where the related charge remains, explicitly defined in the law, has been put up for public consultation until Thursday, August 22, 2024, at 11:00 PM.

The main changes include the following:

Price increases on medicines: Which ones will cost more

Citizens are being significantly burdened in terms of their participation by the drug price increases finalized by the National Organization for Medicines in a list the day before yesterday. Several of the formulations for which the retail price is going up are particularly cheap. However, there are increases of up to 400%, which will be directly reflected in the “pocket” of the insured.

Police seize hazardous Covid supplies in Athens warehouse raids

Police have seized thousands of Covid-19 self-test kits and millions of medical masks deemed hazardous to public health during raids on warehouses in Athens, as shown in a video released on Friday. Two suspects have been apprehended in connection with the case, according to police.

Watchdog warns against online-bought food supplements

The National Organization for Medicines (EOF) issued an advisory on Thursday instructing consumers to exercise caution when purchasing food supplements online, as they may contain dangerous substances.

Specifically, EOF warned against the use of Somatomax and Ecdisten, which contain growth hormones. 

EOF bans distribution of spirulina dietary supplement

The National Organization for Medicines (EOF) has banned the distribution and sale of an imported dietary supplement containing spirulina, citing excessive levels of polycyclic aromatic hydrocarbons (PAHs) exceeding legal limits. 

The decision affects the product "VITAMIR SPIROULINA 500mg" imported from German company OLYMP HANDELS GmbH. 

EU concern over possible shortages in antibiotics

The European Health Emergency Response Authority (HERA) has issued recommendations to pharmaceutical companies to increase production of antibiotics used to treat respiratory infections ahead of winter in an effort to avoid a recurrence of shortages, especially of amoxicillin and amoxicillin/clavulanic acid.

Pages